224
Views
8
CrossRef citations to date
0
Altmetric
Reviews

The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence

, , , , & , MD MSc PhD FRCS
Pages 523-535 | Published online: 03 Aug 2009

Bibliography

  • Wise PM, Krajnak KM, Kashon ML. Menopause: the aging of multiple pacemakers. Science 1996;273(5271):67-70
  • Utian WH, Archer DF, Bachmann GA, et al. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008;15(4 Pt 1):584-602
  • Bruce D, Rymer J. Symptoms of the menopause. Best Pract Res Clin Obstet Gynaecol 2009;23(1):25-32
  • Brincat MP. Oestrogens and the skin. J Cosmet Dermatol 2004;3(1):41-9
  • Brincat M, Studd JWW. Skin and the menopause. In: Studd JWW, Whitehead MI, editors, Blackwell, Oxford, 1988
  • Ashcroft GS, Greenwell-Wild T, Horan MA, et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999;155(4):1137-46
  • Phillips TJ. Chronic cutaneous ulcers: etiology and epidemiology. J Invest Dermatol 1994;102(6):38S-41S
  • Ashcroft GS, Dodsworth J, van Boxtel E, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 1997;3(11):1209-15
  • Berard A, Kahn SR, Abenhaim L. Is hormone replacement therapy protective for venous ulcer of the lower limbs? Pharmacoepidemiol Drug Saf 2001;10(3):245-51
  • Bolognia JL. Aging skin. Am J Med 1995;98(1A):99S-103S
  • Margolis DJ, Knauss J, Bilker W. Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers. Lancet 2002;359(9307):675-77
  • Pierard GE, Letawe C, Dowlati A, Pierard-Franchimont C. Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995;43(6):662-5
  • Verdier-Sevrain S. Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators. Climacteric 2007;10(4):289-97
  • Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol 2005;53(4):555-68; quiz 569-572
  • Phillips TJ, Symons J, Menon S. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women. J Am Acad Dermatol 2008;59(3):397-404, e393
  • White DA, Baxter M. Hormones: biosynthesis and mechanisms of action. Arnold, London, 1994
  • Simpson ER, Mahendroo MS, Means GD, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev, 1994;15(3):342-55
  • Akhtar M, Njar VC, Wright JN. Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes. J Steroid Biochem Mol Biol 1993;44(4-6):375-87
  • Nelson DR, Kamataki T, Waxman DJ, et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 1993;12(1):1-51
  • Mahendroo MS, Mendelson CR, Simpson ER. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 1993;268(26):19463-70
  • Loose-Mitchell DS, Stancel GM. Estrogens and progestins. In: Hardman JG, Limbird LE, editors, McGraw-Hill, New York, 2001
  • Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol, 2001;45(Suppl 3):S116-24
  • Nichols JE, Bulun SE, Simpson ER. Effects of conditioned medium from different cultured cell types on aromatase expression in adipose stromal cells. J Soc Gynecol Investig 1995;2(1):45-50
  • Macdiarmid F, Wang D, Duncan LJ, et al. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha. Mol Cell Endocrinol 1994;106(1-2):17-21
  • Reed MJ, Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev 1997;18(5):701-15
  • Hughss SW, Burley DM. Aminoglutethimide: a “side-effect” turned to therapeutic advantage. Postgrad Med J 1970;46(537):409-16
  • Nabholtz JM. Aromatase inhibitors in the management of early breast cancer. Eur J Surg Oncol 2008;34(11):1199-207
  • Kao YC, Cam LL, Laughton CA, et al. Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study. Cancer Res 1996;56(15):3451-60
  • Geisler J, King N, Dowsett M, et al. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. Br J Cancer 1996;74(8):1286-91
  • Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55(2):74-108
  • Russo J, Hasan Lareef M, Balogh G, et al. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 2003;87(1):1-25
  • Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000;21(3):427-33
  • Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354(3):270-82
  • Miller WR, Mullen P, Telford J, Dixon JM. Clinical importance of intratumoral aromatase. Breast Cancer Res Treat 1998;49(Suppl 1):S27-32; discussion S33-27
  • Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998;22(12):1145-58
  • van Landeghem AA, Poortman J, Nabuurs M, Thijssen JH. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 1985;45(6):2900-06
  • Dunn BK, Ryan A. Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators. Ann NY Acad Sci 2009;1155:141-61
  • Yue W, Santen RJ, Wang JP, et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003;86(3-5):477-86
  • Revankar CM, Cimino DF, Sklar LA, et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005;307(5715):1625-30
  • Cella D, Fallowfield L, Barker P, et al. Quality of life of postmenopausal women in the ATAC (“Arimidex”, tamoxifen, alone or in combination) trial after completion of 5 years adjuvant treatment for early breast cancer. Breast Cancer Res Treat 2006;100(3):273-84
  • Coates AS, Keshaviah A, Thurlimann B, et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 2007;25(5):486-92
  • McCloskey EV, Hannon RA, Lakner G, et al. Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women. Eur J Cancer 2007;43(17):2523-31
  • Buzdar A, Howell A, Cuzick J, et al. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 2006;7(8):633-43
  • Muramatsu M, Inoue S. Estrogen receptors: how do they control reproductive and nonreproductive functions? Biochem Biophys Res Commun 2000;270(1):1-10
  • Thornton MJ. The biological actions of estrogens on skin. Exp Dermatol 2002;11(6):487-502
  • Punnonen R, Lovgren T, Kouvonen I. Demonstration of estrogen receptors in the skin. J Endocrinol Invest 1980;3(3):217-21
  • Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138(3):863-70
  • Taylor AH, Al-Azzawi F. Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol 2000;24(1):145-55
  • Lachgar S, Charveron M, Sarraute J, et al. In vitro main pathways of steroid action in cultured hair follicle cells: vascular approach. J Investig Dermatol Symp Proc 1999;4(3):290-5
  • Hoffmann R. Enzymology of the hair follicle. Eur J Dermatol 2001;11(4):296-300
  • Rhodes L, Argersinger ME, Gantert LT, et al. Effects of administration of testosterone, dihydrotestosterone, oestrogen and fadrozole, an aromatase inhibitor, on sex skin colour in intact male rhesus macaques. J Reprod Fertil 1997;111(1):51-7
  • Bulun SE, Noble LS, Takayama K, et al. Endocrine disorders associated with inappropriately high aromatase expression. J Steroid Biochem Mol Biol, 1997;61(3-6):133-9
  • Coen P, Kulin H, Ballantine T, et al. An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. N Engl J Med 1991;324(5):317-22
  • Dickson RB, Lippman ME. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 1987;8(1):29-43
  • Gilliver SC, Ashworth JJ, Ashcroft GS. The hormonal regulation of cutaneous wound healing. Clin Dermatol 2007;25(1):56-62
  • Labrie F, Belanger A, Luu-The V, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 1998;63(5-6):322-8
  • Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59(3):551-5
  • Calvin M. Oestrogens and wound healing. Maturitas 2000;34(3):195-210
  • Jansson G. Oestrogen-induced enhancement of myeloperoxidase activity in human polymorphonuclear leukocytes–a possible cause of oxidative stress in inflammatory cells. Free Radic Res Commun 1991;14(3):195-208
  • Josefsson E, Tarkowski A, Carlsten H. Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol 1992;142(1):67-78
  • Ito I, Hayashi T, Yamada K, et al. Physiological concentration of estradiol inhibits polymorphonuclear leukocyte chemotaxis via a receptor mediated system. Life Sci 1995;56(25):2247-53
  • Miyagi M, Aoyama H, Morishita M, Iwamoto Y. Effects of sex hormones on chemotaxis of human peripheral polymorphonuclear leukocytes and monocytes. J Periodontol 1992;63(1):28-32
  • Ashcroft GS, Mills SJ, Lei K, et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest 2003;111(9):1309-18
  • Gulshan S, McCruden AB, Stimson WH. Oestrogen receptors in macrophages. Scand J Immunol 1990;31(6):691-7
  • Calvin M, Dyson M, Rymer J, Young SR. The effects of ovarian hormone deficiency on wound contraction in a rat model. Br J Obstet Gynaecol 1998;105(2):223-7
  • Schmidt M, Kreutz M, Loffler G, et al. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol 2000;164(2):161-9
  • Mills SJ, Ashworth JJ, Gilliver SC, et al. The sex steroid precursor DHEA accelerates cutaneous wound healing via the estrogen receptors. J Invest Dermatol 2005;125(5):1053-62
  • Hardman MJ, Waite A, Zeef L, et al. Macrophage migration inhibitory factor: a central regulator of wound healing. Am J Pathol 2005;167(6):1561-74
  • Calandra T, Bucala R. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflamm 1995;47(1-2):39-51
  • Froidevaux C, Roger T, Martin C, et al. Macrophage migration inhibitory factor and innate immune responses to bacterial infections. Crit Care Med 2001;29(Suppl 7):S13-15
  • Zhao Y, Nichols JE, Valdez R, et al. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol Endocrinol 1996;10(11):1350-7
  • Zhao Y, Nichols JE, Bulun SE, et al. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem 1995;270(27):16449-57
  • Zhao Y, Mendelson CR, Simpson ER. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Mol Endocrinol 1995;9(3):340-9
  • Singh A, Purohit A, Ghilchik MW, Reed MJ. The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2. Endocr Relat Cancer, 1999;6(2):139-47
  • Haczynski J, Tarkowski R, Jarzabek K, et al. Human cultured skin fibroblasts express estrogen receptor alpha and beta. Int J Mol Med 2002;10(2):149-53
  • Malet C, Gompel A, Yaneva H, et al. Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: immunocytochemical studies. J Clin Endocrinol Metab 1991;73(1):8-17
  • Pedersen SB, Hansen PS, Lund S, et al. Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue. Eur J Clin Invest 1996;26(4):262-9
  • Tomaszewski J, Adamiak A, Skorupski P, et al. Effect of 17 beta-estradiol and phytoestrogen daidzein on the proliferation of pubocervical fascia and skin fibroblasts derived from women suffering from stress urinary incontinence. Ginekol Pol 2003;74(10):1410-4
  • Morales DE, McGowan KA, Grant DS, et al. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995;91(3):755-63
  • Greenhalgh DG. The role of growth factors in wound healing. J Trauma 1996;41(1):159-67
  • Nath C, Gulati SC. Role of cytokines in healing chronic skin wounds. Acta Haematol 1998;99(3):175-9
  • Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83(3):835-70
  • Clark RA. Regulation of fibroplasia in cutaneous wound repair. Am J Med Sci 1993;306(1):42-8
  • Katz MH, Alvarez AF, Kirsner RS, et al. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol 1991;25(6 Pt 1):1054-8
  • Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988;241(4866):708-12
  • Yang CC, Lin SD, Yu HS. Effect of growth factors on dermal fibroblast contraction in normal skin and hypertrophic scar. J Dermatol Sci 1997;14(2):162-9
  • Shanker G, Sorci-Thomas M, Adams MR. Estrogen modulates the inducible expression of platelet-derived growth factor mRNA by monocyte/macrophages. Life Sci 1995;56(7):499-507
  • Pierce GF, Mustoe TA, Lingelbach J, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989;109(1):429-40
  • Sporn MB, Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 1992;119(5):1017-21
  • Buteau-Lozano H, Ancelin M, Lardeux B, et al. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res 2002;62(17):4977-84
  • Mowa CN, Hoch R, Montavon CL, et al. Estrogen enhances wound healing in the penis of rats. Biomed Res 2008;29(5):267-70
  • Jesmin S, Mowa CN, Matsuda N, et al. Evidence for a potential role of estrogen in the penis: detection of estrogen receptor-alpha and -beta messenger ribonucleic acid and protein. Endocrinology 2002;143(12):4764-74
  • Jesmin S, Mowa CN, Sakuma I, et al. Aromatase is abundantly expressed by neonatal rat penis but downregulated in adulthood. J Mol Endocrinol 2004;33(2):343-59
  • Clark RAF. Wound repair: overview and general considerations. Plenum Press, London, 1996
  • Beck LS, DeGuzman L, Lee WP, et al. One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest 1993;92(6):2841-9
  • Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med 1997;214(1):27-40
  • Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992;339(8787):213-4
  • Nwomeh BC, Liang HX, Cohen IK, Yager DR. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 1999;81(2):189-95
  • Puistola U, Westerlund A, Kauppila A, Turpeenniemi-Hujanen T. Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells. Fertil Steril 1995;64(1):81-7
  • Moalli PA, Klingensmith WL, Meyn LA, Zyczynski HM. Regulation of matrix metalloproteinase expression by estrogen in fibroblasts that are derived from the pelvic floor. Am J Obstet Gynecol 2002;187(1):72-9
  • Pirila E, Ramamurthy N, Maisi P, et al. Wound healing in ovariectomized rats: effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases -8, -13 and type I collagen expression. Curr Med Chem 2001;8(3):281-94
  • Pirila E, Parikka M, Ramamurthy NS, et al. Chemically modified tetracycline (CMT-8) and estrogen promote wound healing in ovariectomized rats: effects on matrix metalloproteinase-2, membrane type 1 matrix metalloproteinase, and laminin-5 gamma2-chain. Wound Repair Regen 2002;10(1):38-51

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.